Leipzig Heart Science Ggmbh
Clinical trials sponsored by Leipzig Heart Science Ggmbh, explained in plain language.
-
Can a temporary heart pump save more lives in cardiogenic shock?
Disease control Not yet recruitingThis trial investigates whether using a temporary heart pump (microaxial flow pump) right after opening a blocked artery improves survival in people with cardiogenic shock—a life-threatening condition where the heart can't pump enough blood. It also tests whether advanced monitor…
Phase: NA • Sponsor: Leipzig Heart Science gGmbH • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
Blood filter may tame deadly inflammation after heart attack
Disease control Not yet recruitingThis trial tests whether filtering a specific inflammatory protein (C-reactive protein, or CRP) from the blood can improve outcomes in people with cardiogenic shock—a life-threatening condition where the heart cannot pump enough blood—after a heart attack. About 50 participants w…
Phase: NA • Sponsor: Leipzig Heart Science gGmbH • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
Ambulance algorithm aims to speed up heart attack diagnosis
Knowledge-focused Not yet recruitingThis study is testing a new algorithm that helps paramedics decide if a patient with chest pain is having a heart attack. About 304 patients will get a quick blood test in the ambulance, and researchers will track their outcomes for 90 days. The goal is to fine-tune the algorithm…
Sponsor: Leipzig Heart Science gGmbH • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:05 UTC